M1 Kliniken - Public Comps and Valuation Multiples

M1 Kliniken Overview

About M1 Kliniken

M1 Kliniken AG is a healthcare company operating in the market for aesthetic medical treatment and plastic surgery. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.

Founded

2007

HQ

Employees

199

Website

m1-kliniken.de

Sectors

Hospitals & Clinics

Financials

Last FY Revenue $398M

Last FY EBITDA $39.3M

EV

$358M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

M1 Kliniken Financials

See M1 Kliniken valuation multiples based on analyst estimates

M1 Kliniken P&L

In the most recent fiscal year, M1 Kliniken reported revenue of $398M and EBITDA of $39.3M.

M1 Kliniken expects next 12-month revenue of XXX and NTM EBITDA of XXX

See M1 Kliniken valuation multiples based on analyst estimates

	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue	XXX	$398M	XXX	XXX	XXX
Gross Profit	XXX	$74.7M	XXX	XXX	XXX
Gross Margin	XXX	19%	XXX	XXX	XXX
EBITDA	XXX	$39.3M	XXX	XXX	XXX
EBITDA Margin	XXX	10%	XXX	XXX	XXX
EBIT	XXX	$30.6M	XXX	XXX	XXX
EBIT Margin	XXX	8%	XXX	XXX	XXX
Net Profit	XXX	$18.8M	XXX	XXX	XXX
Net Margin	XXX	5%	XXX	XXX	XXX
Net Debt	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for M1 Kliniken including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, M1 Kliniken achieved $398M in revenue and $39.3M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2026)	Next Fiscal Year (2027)	Two Years Forward (2028)
Total Revenue	Analyst estimates available to subscribers	$398M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$74.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	18.8% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	$39.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	9.9% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	$30.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	7.7% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	$18.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	4.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for M1 Kliniken

This financial data table provides comprehensive performance metrics for M1 Kliniken, a company based in Germany. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, M1 Kliniken reported $398M in total revenue.
Fiscal year EBITDA was $39.3M.
The company maintained a gross profit margin of 18.8% in the most recent fiscal year.
EBITDA margin for the fiscal year was 9.9%.
Net profit margin reached 4.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for M1 Kliniken. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

M1 Kliniken Stock Performance

M1 Kliniken has current market cap of EUR 341M (or $401M), and EV of EUR 305M (or $358M).

Market Cap Evolution

M1 Kliniken Stock Data

As of January 5, 2026, M1 Kliniken's stock price is EUR 18 (or $21).

See M1 Kliniken trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$358M	$401M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

M1 Kliniken Valuation Multiples

M1 Kliniken's trades at 0.9x EV/Revenue multiple, and 9.1x EV/EBITDA.

See valuation multiples for M1 Kliniken and 15K+ public comps

M1 Kliniken Financial Valuation Multiples

As of January 5, 2026, M1 Kliniken has market cap of $401M and EV of $358M.

Equity research analysts estimate M1 Kliniken's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

M1 Kliniken's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Market cap (current)	$401M	XXX	$401M	XXX	XXX	XXX
EV (current)	$358M	XXX	$358M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	0.9x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	9.1x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	11.7x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	21.3x	XXX	XXX	XXX
EV/FCF	n/a	XXX	10.3x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get M1 Kliniken Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

M1 Kliniken Margins & Growth Rates

M1 Kliniken's revenue per employee in the last FY averaged $2.0M, while opex per employee averaged $0.2M for the same period.

M1 Kliniken's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

M1 Kliniken's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for M1 Kliniken and other 15K+ public comps

M1 Kliniken Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	10%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$2.0M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	1%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	11%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial